RecallDepth
Class III Terminated

Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6592-04.

This recall has been terminated (originally issued April 9, 2025).

Company
The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories
Recall Initiated
March 4, 2025
Posted
April 9, 2025
Recall Number
D-0304-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
224 cartons
Firm Location
La Vergne, TN, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.

Distribution

Nationwide in the USA

Lot / Code Info

Lot# T05393, Exp. Date: 09/30/2025

More recalls by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories

View all recalls by this company →

Other recent Class III Drug recalls